Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine Transdermal System vs Hydrocodone/Acetaminophen in Chronic Back Pain
NCT00315887Phase 3Completed
- Sponsor
- Purdue Pharma
- Start
- Apr 1999
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of buprenorphine in chronic low back pain (CLBP) (3 arms), sponsored by Purdue Pharma. Primary endpoints: Patient Satisfaction With Medication for Pain at Day 56 and Average Pain Intensity at Day 56. Started Apr 1999; status: completed.
02
Drugs
buprenorphine
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT00315887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00315887.